Kazerooni A, Akbari H, Hu X, Bommineni V, Grigoriadis D, Toorens E
Commun Med (Lond). 2025; 5(1):55.
PMID: 40025245
PMC: 11873127.
DOI: 10.1038/s43856-025-00767-0.
Park G, Baek B, Kim S, Yoon W, Park I, Lee Y
Diagnostics (Basel). 2024; 14(19).
PMID: 39410632
PMC: 11482554.
DOI: 10.3390/diagnostics14192228.
Muller S, Khadhraoui E, Henkes H, Ernst M, Rohde V, Schatlo B
Discov Oncol. 2024; 15(1):397.
PMID: 39217585
PMC: 11366735.
DOI: 10.1007/s12672-024-01266-9.
Nayak L, Bettegowda C, Scherer F, Galldiks N, Ahluwalia M, Baraniskin A
Neuro Oncol. 2024; 26(6):993-1011.
PMID: 38598668
PMC: 11145457.
DOI: 10.1093/neuonc/noae032.
Zedde M, Napoli M, Moratti C, Pavone C, Bonacini L, Cecco G
Diagnostics (Basel). 2024; 14(6).
PMID: 38535038
PMC: 10969781.
DOI: 10.3390/diagnostics14060618.
Performance comparison of different medical image fusion algorithms for clinical glioma grade classification with advanced magnetic resonance imaging (MRI).
Khorasani A, Dadashi Serej N, Jalilian M, Shayganfar A, Tavakoli M
Sci Rep. 2023; 13(1):17646.
PMID: 37848493
PMC: 10582165.
DOI: 10.1038/s41598-023-43874-5.
Lymphomas of Central Nervous System.
Yokogami K, Azuma M, Takeshima H, Hirai T
Adv Exp Med Biol. 2023; 1405:527-543.
PMID: 37452952
DOI: 10.1007/978-3-031-23705-8_20.
Evaluation of the Value of Perfusion-Weighted Magnetic Resonance Imaging in the Differential Diagnosis of Sellar and Parasellar Tumors.
Korbecki A, Machaj W, Korbecka J, Sobanski M, Kaczorowski M, Tabakow P
J Clin Med. 2023; 12(8).
PMID: 37109292
PMC: 10144489.
DOI: 10.3390/jcm12082957.
Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma.
Rozenblum L, Houillier C, Soussain C, Bertaux M, Choquet S, Galanaud D
Cancers (Basel). 2022; 14(17).
PMID: 36077613
PMC: 9454946.
DOI: 10.3390/cancers14174071.
Multiparametric MR Imaging Features of Primary CNS Lymphomas.
Talybov R, Beylerli O, Mochalov V, Prokopenko A, Ilyasova T, Trofimova T
Front Surg. 2022; 9:887249.
PMID: 35510125
PMC: 9058099.
DOI: 10.3389/fsurg.2022.887249.
Differentiation of Cerebral Neoplasms with Vessel Size Imaging (VSI).
Foda A, Kellner E, Gunawardana A, Gao X, Janz M, Kufner A
Clin Neuroradiol. 2021; 32(1):239-248.
PMID: 34940899
PMC: 8894153.
DOI: 10.1007/s00062-021-01129-8.
Metabolic Tumor Microenvironment Characterization of Contrast Enhancing Brain Tumors Using Physiologic MRI.
Stadlbauer A, Marhold F, Oberndorfer S, Heinz G, Zimmermann M, Buchfelder M
Metabolites. 2021; 11(10).
PMID: 34677383
PMC: 8537028.
DOI: 10.3390/metabo11100668.
Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.
Kang K, Choi S, Chul-Kee P, Kim T, Park S, Lee J
Eur Radiol. 2021; 31(12):9098-9109.
PMID: 34003350
DOI: 10.1007/s00330-021-08044-z.
Conventional and advanced imaging throughout the cycle of care of gliomas.
Reuter G, Moise M, Roll W, Martin D, Lombard A, Scholtes F
Neurosurg Rev. 2021; 44(5):2493-2509.
PMID: 33411093
DOI: 10.1007/s10143-020-01448-3.
Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas.
Togao O, Chikui T, Tokumori K, Kami Y, Kikuchi K, Momosaka D
PLoS One. 2020; 15(12):e0243839.
PMID: 33315914
PMC: 7737570.
DOI: 10.1371/journal.pone.0243839.
Clinical significance of interleukin-10 concentration in the cerebrospinal fluid of patients with primary central nervous system lymphoma.
Geng M, Song Y, Xiao H, Wu Z, Deng X, Chen C
Oncol Lett. 2020; 21(1):2.
PMID: 33240408
PMC: 7681207.
DOI: 10.3892/ol.2020.12263.
Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features.
Puranik A, Boon M, Purandare N, Rangarajan V, Gupta T, Moiyadi A
World J Nucl Med. 2019; 18(3):266-272.
PMID: 31516370
PMC: 6714153.
DOI: 10.4103/wjnm.WJNM_89_18.
Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee M, Baird G, Bell L, Quarles C, Boxerman J
AJNR Am J Neuroradiol. 2019; 40(9):1445-1450.
PMID: 31371360
PMC: 6728173.
DOI: 10.3174/ajnr.A6153.
Clinical value of magnetic resonance imaging in identifying multiple cerebral gliomas from primary central nervous system lymphoma.
Chen Y, Zhan A
Oncol Lett. 2019; 18(1):593-598.
PMID: 31289531
PMC: 6540358.
DOI: 10.3892/ol.2019.10352.
Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential.
White M, Moore D, Zhang Y, Mark K, Greiner T, Bierman P
Insights Imaging. 2019; 10(1):46.
PMID: 30972513
PMC: 6458224.
DOI: 10.1186/s13244-019-0726-6.